Skip to main content

Advertisement

SpringerLink
Log in

Predictive value of neoadjuvant chemotherapy for the clinical utility of subsequently performed major cancer surgery

  • Editor’s Commentary
  • Published:
Current Oncology Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Adam R, Wicherts DA, de Haas RJ, et al.: Complete pathologic response after preoperative chemotherapy for colorectal liver metastases: myth or reality? J Clin Oncol 2008, 26:1635–1641.

    Article  PubMed  Google Scholar 

  2. Bristow RE, Tomacruz RS, Armstrong DK, et al.: Survival effect of maximal cytoreduction surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 2002, 20:1248–1259.

    Article  PubMed  Google Scholar 

  3. McGuire WP, Hoskins WJ, Brady MF, et al.: Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med 1996, 334:1–6.

    Article  PubMed  CAS  Google Scholar 

  4. Nordlinger B, Sorbye H, Glimelius B, et al.: Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomized controlled trial. Lancet 2008, 371:1007–1016.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The University of Texas M.D. Anderson Cancer Center, Mail Box 121, 1515 Holcombe Boulevard, Houston, TX, 77030, USA

    Maurie Markman

Authors
  1. Maurie Markman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maurie Markman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Markman, M. Predictive value of neoadjuvant chemotherapy for the clinical utility of subsequently performed major cancer surgery. Curr Oncol Rep 10, 447–448 (2008). https://doi.org/10.1007/s11912-008-0068-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11912-008-0068-x

Search

Navigation